Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD
Status:
Withdrawn
Trial end date:
2017-05-05
Target enrollment:
Participant gender:
Summary
To evaluate the safety of 3 regimens of short-term, low-dose systemic IMT as rejection
prophylaxis prior to and/or following transplant of MA09-hRPE cells.